RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1

Authors

  • Amit A. Kulkarni Department of Medical Oncology, Mayo Clinic, Rochester, MN
  • Ganesh Boora Department of Medical Oncology, Mayo Clinic, Rochester, MN
  • Rahul Kanwar Department of Medical Oncology, Mayo Clinic, Rochester, MN
  • Kathryn J. Ruddy Department of Medical Oncology, Mayo Clinic, Rochester, MN; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN
  • Michaela S. Banck Department of Medical Oncology, Mayo Clinic, Rochester, MN; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN
  • Nguyet Le-Lindqwister Illinois Oncology Research Association CCOP, Preoria, IL
  • Terry M. Therneau Division of Bioinformatics and Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
  • Charles L. Loprinzi Department of Medical Oncology, Mayo Clinic, Rochester, MN; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN
  • Andreas S. Beutler Department of Medical Oncology, Mayo Clinic, Rochester, MN; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN

DOI:

https://doi.org/10.3109/0284186X.2014.985388

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2015-09-14

How to Cite

Kulkarni, A. A., Boora, G., Kanwar, R., Ruddy, K. J., Banck, M. S., Le-Lindqwister, N., … Beutler, A. S. (2015). RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1. Acta Oncologica, 54(8), 1227–1229. https://doi.org/10.3109/0284186X.2014.985388

Issue

Vol. 54 No. 8 (2015): Acta Oncologica

Section

Articles